IN VITRO DIAGNOSTICS AltheaDx Inc. AltheaDx 's Series C brings in $30mm AltheaDx Inc. (oncology R&D services and personalized medicine focused on cardio, neuro, and blood disorders) brought in
IN VITRO DIAGNOSTICS CardioDx Inc. CardioDx sells $58mm of Series CC-1 and Series CC-2 preferred shares CardioDx Inc. (cardiovascular diagnostics) has raised $58mm through the sale of Series C